CATEGORIES

"There are many diseases for which mRNA approaches will be life-saving, including cancers"

What are your views on the current application and future perspectives of CRISPR/Cas9 mediated gene editing technology in developing new disease treatments? CRISPR/Caso9 gene editing is very powerful, but, not yet, as highly accurate as one would like.

A Powerful Performance

Allplex SARS-CoV-2 Assay by Seegene Inc

Powering it with RNA

Aspin off from Agency of Science, Technology and Research A*STAR), Singapore-based startup MiRXES has commercialised its technology and eveloped accurate multi-cancer early detection solutions and made them readily available and accessible to people who need them.

Revolutionising Healthcare with New-age Tech

Brain Navi Biotechnology, founded in 2015, is located in Hsinchu Biomedical Science Park in Taiwan.

Accelerating Drug Discovery

Hummingbird Bioscience, founded in 2015, is an innovative clinical-stage biotech startup focused on developing precision therapies against hard-to drug targets to improve treatment outcomes.

Lunit Lunit Inc Conquering Cancer With Al

South Korea-based Lunit Inc is a public company that develops medical artificial intelligence (AI) software that helps conquer cancer.

Far-reaching Impact

Dr Parul Ganju, a PhD in skin biology, from National Institute of Immunology (NII), New Delhi cofounded Ahammune Biosciences in 2016 in Pune, with Dr Krishnamurthy Natarajan, Professor, Jawaharlal Nehru University (JNU), New Delhi.

Applying Deep Learning Experience to Drug Discovery

A leader in next-generation artificial intelligence (AI) technologies for drug discovery and biomarker development, Alex Zhavoronkov, PhD, is the founder and Chief Executive Officer of Hong Kong headquartered startup Insilico Medicine.

An International Leader in Vaccinology

With an extensive background in child health and immunisation research, Professor Helen Marshall is best known for leading the world’s biggest study on meningococcal B disease.

BioSpectrum Asia Honours Industry Stalwarts

Asia has, indeed, become the new hub for potential growth and innovation, with no signs of losing steam.

Quadripartite launches new platform to tackle AMR threat to human, animal health

The Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform has been launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.

WHO inks new MoU on health workforce priorities

The World Health Organisation (WHO) has signed a Memorandum of Understanding (MoU) with the five members of the World Health Professions Alliance (WHPA), World Dental Federation (FDI),

WHO to identify pathogens likely to cause future outbreaks and pandemics

The World Health Organisation (WHO) is launching a global scientific process to update the list of priority pathogens, agents that can cause outbreaks or pandemics, to guide global investment, research and development (R&D), especially in vaccines, tests and treatments.

Global health agencies support Uganda against outbreak of Ebolavirus disease

Following the declaration of an Ebola outbreak in Uganda on September 20, 2022, the outbreak has now spread to seven districts (Kasanda, Kyegegwa, Bunyangabu and Kagadi districts beyond the original epicentre in Mubende district, and then to Kampala City and Wakiso).

Oral cholera vaccine receives manufacturing push for African & global markets

South Africa based biopharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).

Tackling emerging antimalarial drug resistance in Africa

The World Health Organisation (WHO) has launched a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa.

New Dutch Global Health Strategy calls for stronger cooperation

The Netherlands discussed its new strategy for Global Health with the World Health Organisation (WHO) and called for deeper coordination with the organisation to improve global health – aiming to strengthen health systems at home and worldwide, better prepare for pandemics and address the impact of climate change on public health.

Improved provision of mental health services to benefit Lithuanian youth

Strengthened governance and delivery of mental health services will improve the well-being of young people in Lithuania, according to a new World Bank report.

Lunit accelerates AI-powered medical imaging across major overseas channels

South Korea-based startup Lunit has signed a global distribution agreement with Indian firm CARPL.ai, an end-to-end healthcare technology platform that enables the development, validation, and deployment of artificial intelligence (AI) solutions across clinical workflows.

Qmed Asia eyes APAC expansion with digital health solutions

Malaysian startup Qmed Asia has announced regional expansion into Taiwan, Indonesia, Vietnam, and Cambodia to introduce value-added services to healthcare segments and patients in the form of innovative digital health solutions that are accessible, affordable, and reliable.

RVAC Medicines, A*STAR to build capabilities for mRNA production in Singapore

RVAC Medicines, a messenger RNA (mRNA) technology platform startup incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) have announced the signing of a master research collaboration agreement to jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.

ANDHealth, LaunchVic launch Digital Health Accelerator in Australia

ANDHealth, Australia’s leading digital health commercialisation organisation, has successfully secured $1.4 million in funding from LaunchVic to establish a novel accelerator programme for high growth potential digital health startups.

MIRXES announces Southeast Asia's first business and clinical advisory programme

MiRXES, a Singapore-headquartered biotechnology startup focused on saving lives and improving health economics and outcomes through RNA-powered disease early detection and precision genomic tests, has launched the first edition of MiRXES Translator Programme,

Medtronic launches Customer eXperience Center in Singapore

Medtronic plc, a global leader in healthcare technology, has launched the Medtronic Customer eXperience Center (MCXC) in Singapore, leveraging innovative healthcare technologies across extended reality (XR), augmented and virtual realities, and robotics, to connect the global healthcare community from anywhere, at any time.

QPS opens new preclinical research facility in Taiwan

QPS, a global contract research organisation headquartered in the US, has opened a second preclinical research facility in Taipei, Taiwan.

Boston Scientific expands operations in Malaysia

Boston Scientific Corporation, a global leader in medical device technology, has unveiled a new expansion of its operations in Batu Kawan, Penang, Malaysia.

XtalPi, CK Life Sciences announce AIempowered tumour vaccine R&D in China

Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group.

Astellas invests $50M to support gene therapy programmes of Taysha

Japan-based Astellas Pharma Inc. and Taysha Gene Therapies, Inc. have announced a strategic investment to support the advancement of Taysha’s adeno-associated virus (AAV) gene therapy development programmes for the treatment of Rett syndrome and Giant Axonal Neuropathy (GAN).

GSK launches S$44M HPF in Singapore for cancer treatment

The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.

CSIRO partnership helps connect Australian healthcare system

The Australian Digital Health Agency and Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisation (CSIRO)’s